About the Company
voyager therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (cns). voyager is committed to advancing the field of aav (adeno-associated virus) gene therapy through innovation and investment in vector optimization and engineering, dosing techniques, as well as process development and production. the company’s initial pipeline is focused on cns diseases in dire need of effective new therapies, including parkinson’s disease, a monogenic form of amyotrophic lateral sclerosis (als), and friedreich’s ataxia. founded by scientific and clinical leaders in the fields of aav gene therapy, expressed rna interference and neuroscience, voyager therapeutics was launched in 2014 with funding from leading life sciences investor third rock ventures and is headquartered in cambridge, mass. for more information, please visit www.voyagertherapeutics.com.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $VYGR News
Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer
LEXINGTON, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: VYGR), a biotechnology company dedicated to advancing ...
Voyager Therapeutics: On Track To Deliver High Returns On Investment
In this article, I will be providing a financial and scientific analysis of Voyager Therapeutics Inc. (NASDAQ:VYGR). Financially speaking, Voyager is still due to live up to its expectations ...
Voyager Therapeutics (NASDAQ: VYGR)
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes ...
Voyager 1 is 15 billion miles from home and broken. Here's how NASA is trying to fix it.
Voyager 1, which left Earth 46 years ago, is now 15 billion miles away. NASA is sifting through computer codes and old ...
NASA scientist viewed first Voyager images. What he saw gave him chills.
In 1979, Alan Cummings, a scientist working on NASA's unprecedented Voyager mission, entered a Caltech room in Pasadena, ...
NASA gave Voyager 1 a 'poke' amid communication woes. Here's why the response was encouraging.
The mission of one of NASA's twin Voyager space probes has been in peril for months as the agency has been unable to receive ...
Aging Voyager 1 sends back surprising response after ‘poke’ from Earth
A “poke” sent to the Voyager 1 probe received a response that could help NASA restore reliable communication with the aging ...
Finally, engineers have a clue that could help them save Voyager 1
Suzanne Dodd, NASA's project manager for Voyager 1 and its twin, Voyager 2, recently told Ars that engineers would need to ...
Voyager Therapeutics Appoints Toby Ferguson As Chief Medical Officer
Biotechnology company Voyager Therapeutics, Inc. (VYGR) announced the appointment of Toby Ferguson as Chief Medical Officer (CMO), ...
Voyager Therapeutics, Inc.: Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer
Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced the appointment ...
Loading the latest forecasts...